S. K. Lee

Inactivating mutations of KILLER/DR5 gene in gastric cancers.

H. S. Kim, S. H. Lee, C. H. Park, 2001, Gastroenterology.

MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.

M. Gottesman, T. Tsuruo, K. Choe, 1994, Journal of the National Cancer Institute.

Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng).

S. K. Lee, Hyung Sik Kim, B. Lee, 1998, Cancer letters.

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

M. Ahn, S. K. Lee, Y. Son, 2008, British Journal of Cancer.

Oxidation of erythrocyte protein and lipid, and hemolysis in rabbit red blood cells treated with benzo[a]pyrene or adriamycin.

S. K. Lee, B. M. Lee, S. K. Lee, 1997, Journal of toxicology and environmental health.

Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis.

W. Choi, S. K. Lee, Se Hwan Mun, 2012, Cellular signalling.

Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.

H. S. Kim, S. H. Lee, M. Shin, 2001, Cancer research.